Pin-point™ base editing reagents

Accelerating therapeutic development and reach into the clinic

Revvity's Pin-point base editing platform offers a unique and powerful approach for safe and more effective complex genetic engineering. This page is dedicated for our Pin-point base editing reagents that are available for research use only. The Pin-point™ base editing platform technology is also available for clinical or diagnostic study and commercialization under a commercial license from Revvity. To learn more about potential licensing and service options please visit revvity.com
Modular Pin-point™ base editing system facilitates highly efficient and precise nucleotide conversion with the potential for multiplex gene editing capabilities. The modularity of the system means we can offer a customizable, off-the-shelf system for base editing.
Pin-point base editing technology

Revvity's Pin-point base editing technology is a three-component system featuring a nickase Cas9 which recruits the effector deaminase through fusion to an aptamer-binding protein. The aptamer is linked to the guide RNA associated with the nuclease in an extended, chimeric RNA scaffold. The modular nature of effector recruitment means that nCas9 can be used for the knockout of one or more gene targets while simultaneously inserting a transgene.

Now available for your base editing applications, these required components

  1. Guide RNA with patented and proprietary aptamer
  2. Modified Cas9 - nickase Cas9 (nCas9)
  3. Deaminase fused to an aptamer binding protein
The guide RNA directs the modified Cas9 to the precise location on the targeted DNA
The guide RNA directs the modified Cas9 to the precise location on the targeted DNA
Modified Cas9 nicks a single strand of the targeted DNA
Modified Cas9 nicks a single strand of the targeted DNA
The recruited deaminase performs the base edit on the opposite strand
The recruited deaminase performs the base edit on the opposite strand
Benefits of Pin-point base editing platform include:
  • MODULAR SYSTEM for optimized research
  • HIGH EFFICIENCY gene editing platform
  • MULTIPLEX EDITING across several targets
  • IMPROVED SAFETY over standard CRISPR-Cas9
  • VERSATILE TECHNOLOGY for targeted editing
  • VALIDATED PERFORMANCE in T cells and iPSCs
Read publications about the Pin-point base editing platform: